United States: There’s Clear Evidence FDA Rejected Fosamax Femur Fracture Warning
WASHINGTON, D.C. — The United States on Sept. 20 sided with Merck Sharp & Dohme that there is clear evidence that the Food and Drug Administration rejected a stronger warning about...To view the full article, register now.
Already a subscriber? Click here to view full article